What is he best known for?
The fields of study he is best known for:
Immunology, Virology, Major histocompatibility complex, Hepatitis C virus and Epitope are his primary areas of study.
Christopher M. Walker is interested in Virus, which is a field of Immunology.
His research investigates the link between Virus and topics such as Antibody that cross with problems in Interleukin 21 and T cell.
His Virology study combines topics in areas such as Immunity, CD8, Immune system, Antigen and Cytotoxic T cell.
Christopher M. Walker focuses mostly in the field of Epitope, narrowing it down to topics relating to CTL* and, in certain cases, Viral quasispecies and Hepatitis C.
His Muscular dystrophy research integrates issues from Limb-girdle muscular dystrophy, SGCA, Extensor digitorum brevis muscle and Skeletal muscle.
His most cited work include:
- CD8+ lymphocytes can control HIV infection in vitro by suppressing virus replication (899 citations)
- HCV Persistence and Immune Evasion in the Absence of Memory T Cell Help (720 citations)
- Adaptive immune responses in acute and chronic hepatitis C virus infection (676 citations)
What are the main themes of his work throughout his whole career to date?
His primary scientific interests are in Virology, Immunology, Virus, Epitope and CD8.
His biological study spans a wide range of topics, including Cytotoxic T cell and T cell, Immune system.
His Immunology study incorporates themes from Transmission, Muscular dystrophy and Toxicity.
His Virus research is multidisciplinary, incorporating perspectives in Antibody, Antigenicity, Immunogenicity and Signal peptide.
The various areas that Christopher M. Walker examines in his Epitope study include Molecular biology, MHC class I, Peptide binding, Major histocompatibility complex and Skeletal muscle.
The study incorporates disciplines such as Interferon and T lymphocyte in addition to CD8.
He most often published in these fields:
- Virology (96.97%)
- Immunology (90.91%)
- Virus (52.53%)
What were the highlights of his more recent work (between 2013-2021)?
- Virology (96.97%)
- Virus (52.53%)
- Immunology (90.91%)
In recent papers he was focusing on the following fields of study:
His primary areas of investigation include Virology, Virus, Immunology, Hepatitis C virus and T cell.
The Virology study combines topics in areas such as CD8 and Immunity.
His studies deal with areas such as Epitope, Cytotoxic T cell, Hepatitis E and Signal peptide as well as Virus.
Christopher M. Walker combines subjects such as Disease and Toxicity with his study of Immunology.
His research integrates issues of Secondary infection, Hepatitis C and Hepatitis in his study of Hepatitis C virus.
Christopher M. Walker has researched T cell in several fields, including Viremia, Viral vector and Chronic infection.
Between 2013 and 2021, his most popular works were:
- Major histocompatibility complex class I molecules protect motor neurons from astrocyte-induced toxicity in amyotrophic lateral sclerosis (74 citations)
- Major histocompatibility complex class I molecules protect motor neurons from astrocyte-induced toxicity in amyotrophic lateral sclerosis (74 citations)
- Human pDCs preferentially sense enveloped hepatitis A virions (61 citations)
In his most recent research, the most cited papers focused on:
Christopher M. Walker mainly focuses on Virology, Immunology, Toxicity, Capsid and Antigenicity.
Much of his study explores Virology relationship to Antibody.
His study in Secondary infection, Hepatitis C virus, Interferon, T cell and CD8 is carried out as part of his studies in Immunology.
His work deals with themes such as MHC class I, Major histocompatibility complex and Neuroscience, Cellular neuroscience, which intersect with Toxicity.
His Capsid research includes themes of Hepatitis E virus, Epitope, Hepatitis E and Signal peptide.
Christopher M. Walker undertakes interdisciplinary study in the fields of Antigenicity and Start codon through his research.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
